tiprankstipranks
Vaxil Bio Ltd (TSE:VXL)
:VXL
Canadian Market
VXL
Vaxil Bio
RESEARCH TOOLSreports
Want to see TSE:VXL full AI Analyst Report?

Vaxil Bio (VXL) Financial Statements

22 Followers

Vaxil Bio Financial Overview

Vaxil Bio's market cap is currently C$1.06M. The company's EPS TTM is C$0.02; its P/E ratio is -6.34; Vaxil Bio is scheduled to report earnings on April 23, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ -2.00KC$ -25.00KC$ -57.00K
Operating IncomeC$ -196.00KC$ -254.00KC$ -584.00KC$ -986.00KC$ -1.35M
EBITDAC$ -178.00KC$ -252.00KC$ -582.00KC$ -961.00KC$ -1.29M
Net IncomeC$ -178.00KC$ -254.00C$ -584.00KC$ -986.00KC$ -1.36M
Balance Sheet
Cash & Short-Term InvestmentsC$ 714.00KC$ 938.00KC$ 1.51MC$ 2.24MC$ 1.51M
Total AssetsC$ 733.00KC$ 976.00KC$ 1.54MC$ 2.29MC$ 1.66M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 9.00K
Net DebtC$ -448.00KC$ -938.00KC$ -1.51MC$ -2.24MC$ -1.50M
Total LiabilitiesC$ 17.00KC$ 85.00KC$ 405.00KC$ 585.00KC$ 857.00K
Stockholders' EquityC$ 716.00KC$ 891.00KC$ 1.14MC$ 1.70MC$ 804.00K
Cash Flow
Free Cash FlowC$ -240.00KC$ -561.00KC$ -734.00KC$ -1.08MC$ -1.10M
Operating Cash FlowC$ -240.00KC$ -561.00KC$ -734.00KC$ -1.08MC$ -1.10M
Investing Cash FlowC$ -250.00KC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 1.81MC$ 2.56M
Currency in CAD

Vaxil Bio Earnings and Revenue History

Income Statement >

Vaxil Bio Debt to Assets

Balance Sheet >

Vaxil Bio Cash Flow

Cash Flow >

Vaxil Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >